Krilogy Financial
IRWD icon

Krilogy Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Krilogy Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$83.1K Sell
22,101
-4,247
-16% -$17.7K ﹤0.01% 1060
2026
Q2 		$111K Sell
26,348
-6,846
-21% -$26.4K ﹤0.01% 1003
2026
Q1 		$144K Buy
33,194
+2,971
+10% +$12.2K ﹤0.01% 921
2025
Q4 		$157K Buy
30,223
+15
+0% +$39 0.01% 893
2025
Q3 		$62.2K Buy
+30,208
New +$31.3K ﹤0.01% 850

Other funds holding IRWD

CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Kathmere Capital Management
Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Krilogy Financial's IRWD Position: Q3 2026 in Review

Krilogy Financial reduced its Ironwood Pharmaceuticals (IRWD) stake by 16% in Q3 2026, selling an estimated $17.7K and leaving 22,101 shares worth $83.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

Krilogy Financial first reported a position in IRWD in Q3 2025 and has held it in 5 quarters since. The position peaked at $157K in Q4 2025. 21 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Krilogy Financial held 22,101 shares of Ironwood Pharmaceuticals worth $83.1K as of Q3 2026.
  • Krilogy Financial sold 4,247 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $17.7K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Krilogy Financial's portfolio in Q3 2026, its #1060 holding.
  • Krilogy Financial first reported a position in Ironwood Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Krilogy Financial's Ironwood Pharmaceuticals position peaked at $157K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.